Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Monday November 14 2022 to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30 2022 amongst other matters.Further as per provisions of the Companys Code of Conduct for Prohibition of Insider Trading trading window for Designated Persons of the Company is closed from Saturday October 1 2022 upto Wednesday November 16 2022 (both days inclusive).This is for your kind information and record purposes.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
